ArticleCancer2019

Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma.

Stefania Maraka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.